Htalogo
Vagal Nerve Stimulation
 Print  Email Share Bookmark & Share

Topic Summary

Concerns about safety, efficacy and costs regarding whether Vagal Nerve Stimulation (VNS) provides adequate treatment for epilepsy and depression. VNS has been shown to affect blood flow to different parts of the brain, and affect neurotransmitters which are implicated in depression. Important clinical questions remain, especially around the efficacy of using of VNS to treat epilepsy and depression.

  • Draft Report Published: July 10, 2009
  • Public Comment Period: July 10 - 24, 2009
  • Final Report Published: July 31, 2009
  • HTCC Public Meeting: August 28, 2009

Primary Criteria Ranking

Safety = High
Efficacy = High
Cost = High

Documents

Public Comments and Responses (760.1 KB)
Updated Final Evidence Report (687.1 KB)
Final Key Questions (122 KB)
Findings and Decision (236 KB)